









市场行情
/
股票
/
nasdaq-dva
/

DaVita Inc

DVA

121.370USD

+1.880+1.57%

收盘 11/25, 16:00（美东）报价延迟15分钟

8.61B总市值

11.16市盈率 TTM



DaVita Inc

121.370

+1.880+1.57%

概览公司财务分析

概览

公司

财务

分析

关于 DaVita Inc 公司

DaVita Inc. 是一家医疗保健提供商，致力于改变医疗服务方式，改善全球患者的生活质量。该公司是美国肾脏护理服务提供商。其美国透析（US dialysis）和相关实验室服务业务为患有慢性肾衰竭和终末期肾病（ESKD）的患者提供治疗。该公司强大的平台提供肾脏护理服务，并包括已建立的肾病学和付款人关系。该公司的国际业务为总共门诊透析中心提供透析和行政服务。该公司的美国综合肾脏护理（IKC）业务为美国各地基于风险的综合护理安排中的患者和其他综合护理安排中的其他患者提供综合护理和疾病管理服务。它还在美国透析、美国 IKC 或国际业务之外维持一些其他辅助服务和投资。

DaVita Inc简介



公司代码DVA

公司名称DaVita Inc

上市日期Oct 31, 1995

CEOMr. Javier J. Rodriguez

员工数量76000

证券类型Ordinary Share

年结日Oct 31

公司地址2000 16th St

城市DENVER

上市交易所NYSE Consolidated

国家United States of America

邮编80202-5117

电话13105362668

网址https://www.davita.com/

公司代码DVA

上市日期Oct 31, 1995

CEOMr. Javier J. Rodriguez

DaVita Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Javier J. Rodriguez

Chief Executive Officer, Director

832.67K

-0.62%

Mr. Joel Ackerman

Chief Financial Officer, Treasurer

101.00K

+8.83%

Ms. Kathleen Alyce Waters

Chief Legal and Public Affairs Officer

66.98K

+12.40%

Ms. Pamela M. Arway

Independent Chair of the Board

26.36K

+1.58%

Mr. Christopher Michael (Chris) Berry

Chief Accounting Officer

15.96K

+31.62%

Mr. James O. Hearty

Chief Compliance Officer

14.28K

-14.14%

Ms. Phyllis R. Yale

Independent Director

13.98K

+3.03%

Ms. Barbara J. Desoer

Independent Director

13.44K

+3.15%

Mr. David P. Maughan

Chief Operating Officer - Davita Kidney Care

13.08K

-36.44%

Dr. Gregory J. Moore, M.D., Ph.D.

Independent Director

7.23K

+6.03%

名称

名称/职务

职务

持股

持股变动

Mr. Javier J. Rodriguez

Chief Executive Officer, Director

832.67K

-0.62%

Mr. Joel Ackerman

Chief Financial Officer, Treasurer

101.00K

+8.83%

Ms. Kathleen Alyce Waters

Chief Legal and Public Affairs Officer

66.98K

+12.40%

Ms. Pamela M. Arway

Independent Chair of the Board

26.36K

+1.58%

Mr. Christopher Michael (Chris) Berry

Chief Accounting Officer

15.96K

+31.62%

Mr. James O. Hearty

Chief Compliance Officer

14.28K

-14.14%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Patient service - Medicare and Medicare Advantage

1.66B

49.11%

Patient service - Commercial

1.04B

30.72%

Patient service - Other government

308.04M

9.11%

Patient service - Medicaid and Managed Medicaid

217.70M

6.44%

Other - Medicare and Medicare Advantage

140.15M

4.15%

其他

15.79M

0.47%

由于公司未披露，未能获取相关数据

业务

地区

业务USD

名称

营收

占比

Patient service - Medicare and Medicare Advantage

1.66B

49.11%

Patient service - Commercial

1.04B

30.72%

Patient service - Other government

308.04M

9.11%

Patient service - Medicaid and Managed Medicaid

217.70M

6.44%

Other - Medicare and Medicare Advantage

140.15M

4.15%

其他

15.79M

0.47%

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

Berkshire Hathaway Inc.

44.98%

The Vanguard Group, Inc.

5.96%

BlackRock Institutional Trust Company, N.A.

3.39%

Weschler (R Ted)

3.09%

State Street Investment Management (US)

2.60%

其他

39.97%

持股股东

占比

Berkshire Hathaway Inc.

44.98%

The Vanguard Group, Inc.

5.96%

BlackRock Institutional Trust Company, N.A.

3.39%

Weschler (R Ted)

3.09%

State Street Investment Management (US)

2.60%

其他

39.97%

股东类型

持股股东

占比

Holding Company

44.99%

Investment Advisor

25.66%

Investment Advisor/Hedge Fund

14.46%

Hedge Fund

5.46%

Individual Investor

5.06%

Research Firm

2.42%

Pension Fund

2.16%

Bank and Trust

0.87%

Sovereign Wealth Fund

0.35%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

1270

35.96M

50.94%

-3.88M

2025Q2

1278

73.92M

100.87%

-6.43M

2025Q1

1300

76.19M

99.78%

-5.46M

2024Q4

1260

79.70M

99.28%

-3.76M

2024Q3

1214

80.97M

98.10%

-3.96M

2024Q2

1180

82.28M

96.62%

-4.32M

2024Q1

1166

84.15M

95.98%

-4.07M

2023Q4

1163

84.91M

95.56%

-3.04M

2023Q3

1159

85.40M

93.52%

-3.20M

2023Q2

1164

84.27M

92.30%

-4.64M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Berkshire Hathaway Inc.

32.16M

44.98%

-1.64M

-4.84%

Jul 31, 2025

The Vanguard Group, Inc.

4.73M

6.61%

-306.08K

-6.08%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.64M

3.69%

-276.40K

-9.48%

Jun 30, 2025

Weschler (R Ted)

2.18M

3.05%

Aug 06, 2024

State Street Investment Management (US)

2.09M

2.93%

-103.39K

-4.71%

Jun 30, 2025

Invesco Capital Management LLC

1.34M

1.88%

+33.33K

+2.55%

Jun 30, 2025

Gates Capital Management, Inc.

1.10M

1.54%

+376.77K

+52.17%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

997.53K

1.4%

+120.21K

+13.70%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.11M

1.55%

-76.77K

-6.47%

Jun 30, 2025

LSV Asset Management

940.73K

1.32%

-21.60K

-2.24%

Jun 30, 2025

持股ETF



更新时间: 11月6日周四

机构名称

占比

Strategas Global Policy Opportunities ETF

1.99%

SPDR S&P Health Care Services ETF

1.91%

Aztlan Global Stock Selection DM SMID ETF

1.84%

Invesco S&P 500 Equal Weight Health Care ETF

1.65%

Global X US Cash Flow Kings 100 ETF

1.52%

Pacer US Cash Cows Growth ETF

1.1%

LeaderShares AlphaFactor US Core ETF

Global X Aging Population ETF

0.81%

iShares U.S. Healthcare Providers ETF

0.78%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

0.75%

Strategas Global Policy Opportunities ETF

占比1.99%

SPDR S&P Health Care Services ETF

占比1.91%

Aztlan Global Stock Selection DM SMID ETF

占比1.84%

Invesco S&P 500 Equal Weight Health Care ETF

占比1.65%

Global X US Cash Flow Kings 100 ETF

占比1.52%

Pacer US Cash Cows Growth ETF

占比1.1%

LeaderShares AlphaFactor US Core ETF

占比1%

Global X Aging Population ETF

占比0.81%

iShares U.S. Healthcare Providers ETF

占比0.78%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

占比0.75%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

DaVita Inc的前五大股东是谁？



DaVita Inc 的前五大股东如下：
Berkshire Hathaway Inc.持有股份：32.16M，占总股份比例：44.98%。
The Vanguard Group, Inc.持有股份：4.73M，占总股份比例：6.61%。
BlackRock Institutional Trust Company, N.A.持有股份：2.64M，占总股份比例：3.69%。
Weschler (R Ted)持有股份：2.18M，占总股份比例：3.05%。
State Street Investment Management (US)持有股份：2.09M，占总股份比例：2.93%。